Why did Microbot Medical stock rise on 7 October?
Written after the close on
Microbot Medical +4.67%
Microbot Medical jumped on an Israel distribution deal. Over the last five trading days Microbot Medical fell sharply, even as the broad market rose clearly and the healthcare sector was roughly flat, so the week and the latest session went opposite ways. The likely driver of the latest session was the exclusive three-year distribution agreement with Medtechnica to sell its LIBERTY robotic surgical system in Israel, announced the day before; that is a commercial partner deal, meaning an outside company will handle sales and marketing in that country. The earlier weakness over the five days looks partly like profit-taking after a run and partly like concern over the company's cash burn — the rate at which a still-unprofitable business spends money — since it does not yet generate meaningful revenue. What to watch next is whether the Israel launch translates into actual placements and sales, and whether the company raises more cash.